BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX

Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...

March 07, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

March 06, 2024 | News

Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

March 06, 2024 | News

Naveris Inc. Launches Pioneering NAVigate-HPV Registry to Enhance HPV Cancer Diagnostics

-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of the NAVigate-HPV Registry. This innov...

March 04, 2024 | News

VinBrain and Global Fund Partner to Fight Tuberculosis in Vietnam with AI in 2024

VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain's in...

February 29, 2024 | News

Huawei Introduces Solution for Smarter Healthcare through Medical Tech Digitalization

David Shi, Vice President of Huawei's ICT Marketing & Solution Sales, said, "To accelerate the intelligent upgrade of the healthcare industry, Huawei, ...

February 29, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

February 26, 2024 | News

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...

February 19, 2024 | News

AffaMed's NDA for DEXTENZA Accepted by Singapore HSA for Post-Surgery Ocular Treatment

AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products&...

February 19, 2024 | News

AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand

AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...

February 19, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

February 19, 2024 | News

Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)

Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...

February 17, 2024 | News

Stay Connected